What Can Urine Tell Us About Medication Adherence?

por Anderson, Peter L.
Publicado 2018

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women

por Anderson, Peter L., Reirden, Daniel, Castillo-Mancilla, Jose
Publicado 2016

Beyond HIV viral load: application of pharmacologic measures to identify ART adherence mismatch

por Kristofich, Michael, Anderson, Peter L., Castillo-Mancilla, Jose R.
Publicado 2021

Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV

por von Kleist, Max, García-Lerma, J. Gerardo, Liu, Albert, Anderson, Peter L.
Publicado 2020

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing

por Innes, Steve, van der Laan, Louvina, Anderson, Peter L., Cotton, Mark, Denti, Paolo
Publicado 2018

The ATEAM study: Advances in technology to enhance PrEP adherence monitoring (ATEAM) among young men who have sex with men

por Brothers, Jennifer, Hosek, Sybil, Keckler, Kody, Anderson, Peter L., Xiong, Di, Liu, Honghu, Huhn, Gregory
Publicado 2022

999. Using the F/TDF Adherence-Efficacy Relationship to Calculate Background HIV incidence: Results from the DISCOVER trial

por Glidden, David V, Dunn, David T, Das, Moupali, Ebrahimi, Ramin, Zhong, Lijie, Stirrup, Oliver T, Anderson, Peter L
Publicado 2020

Using the adherence‐efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled...

por Glidden, David V, Das, Moupali, Dunn, David T, Ebrahimi, Ramin, Zhao, Yongwu, Stirrup, Oliver T, Baeten, Jared M, Anderson, Peter L
Publicado 2021

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

por Adje, Yeba H., Brooks, Kristina M., Castillo-Mancilla, Jose R., Wyles, David L., Anderson, Peter L., Kiser, Jennifer J.
Publicado 2022

Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 ra...

por Velloza, Jennifer, Hosek, Sybil, Donnell, Deborah, Anderson, Peter L, Chirenje, Mike, Mgodi, Nyaradzo, Bekker, Linda‐Gail, Delany‐Moretlwe, Sinead, Celum, Connie
Publicado 2021

Associations Between Tenofovir Diphosphate in Dried Blood Spots, Impaired Physical Function, and Fracture Risk

por Abdo, Mona, Coyle, Ryan P, Seifert, Sharon M, Castillo-Mancilla, Jose R, Jankowski, Catherine M, Mawhinney, Samantha, Anderson, Peter L, Erlandson, Kristine M
Publicado 2020

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates

por Chen, Xinhui, Seifert, Sharon M., Castillo-Mancilla, Jose R., Bushman, Lane R., Zheng, Jia-Hua, Kiser, Jennifer J., MaWhinney, Samantha, Anderson, Peter L.
Publicado 2016

A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir

por Thurman, Andrea R., Ouattara, Louise A., Yousefieh, Nazita, Anderson, Peter L., Bushman, Lane R., Fang, Xi, Hanif, Homaira, Clark, Meredith, Singh, Onkar, Doncel, Gustavo F.
Publicado 2023

Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study

por Beauchamp, Geetha, Donnell, Deborah, Hosek, Sybil, Anderson, Peter L., Chan, Kwun C. G., Dye, Bonnie J., Mgodi, Nyaradzo, Bekker, Linda-Gail, Delany-Moretlwe, Sinead, Celum, Connie
Publicado 2023

Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men

por van den Elshout, Mark AM, Hoornenborg, Elske, Coyer, Liza, Anderson, Peter L, Davidovich, Udi, de Vries, Henry JC, Prins, Maria, Schim van der Loeff, Maarten F
Publicado 2023

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men

por Hoenigl, Martin, Jain, Sonia, Moore, David, Collins, Deborah, Sun, Xiaoying, Anderson, Peter L., Corado, Katya, Blumenthal, Jill S., Daar, Eric S., Milam, Joel, Dubé, Michael P., Morris, Sheldon
Publicado 2018

Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV Prevention

por Tong, Xin, Patel, Sravan Kumar, Li, Jing, Patton, Dorothy, Xu, Elaine, Anderson, Peter L., Parikh, Urvi, Sweeney, Yvonne, Strizki, Julie, Hillier, Sharon L., Rohan, Lisa C.
Publicado 2022

Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)

por Liu, Albert Y., Yang, Qiyun, Huang, Yong, Bacchetti, Peter, Anderson, Peter L., Jin, Chengshi, Goggin, Kathy, Stojanovski, Kristefer, Grant, Robert, Buchbinder, Susan P., Greenblatt, Ruth M., Gandhi, Monica
Publicado 2014

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial

por Baxi, Sanjiv M., Vittinghoff, Eric, Bacchetti, Peter, Huang, Yong, Chillag, Kata, Wiegand, Ryan, Anderson, Peter L., Grant, Robert, Greenblatt, Ruth M., Buchbinder, Susan, Gandhi, Monica, Liu, Albert Y.
Publicado 2018

Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV

por Castillo-Mancilla, Jose R, Morrow, Mary, Coyle, Ryan P, Coleman, Stacey S, Zheng, Jia-Hua, Ellison, Lucas, Bushman, Lane R, Kiser, Jennifer J, Anderson, Peter L, MaWhinney, Samantha
Publicado 2021